Reduced Time in Therapeutic Range and Higher Mortality in Atrial Fibrillation Patients Taking Acenocoumarol

José Miguel Rivera‐Caravaca; Vanessa Roldán; María Asunción Esteve‐Pastor; Mariano Valdés; Vicente Vicente; Francisco Marı́n; Professor Gregory Lip

doi:10.1016/j.clinthera.2017.11.014

Related publications

Article2016

Female Sex, Time in Therapeutic Range, and Clinical Outcomes in Atrial Fibrillation Patients Taking Warfarin

Keitaro Senoo, Professor Gregory Lip

Article2018

Temporal trends of time in therapeutic range and incidence of cardiovascular events in patients with non-valvular atrial fibrillation

Daniele Pastori, Alessio Farcomeni, Mirella Saliola, Francesco Del Sole, Pasquale Pignatelli, Francesco Violi, Professor Gregory Lip, Marco Casciaro, Domenico Ferro, Danilo Menichelli, Roberto Carnevale, Fabiana Albanese, Tiziana Di Stefano, Patrizia Iannucci, Elio Sabbatini, Claudia Iannilli

Article2018

Time to therapeutic range (TtTR), anticoagulation control, and cardiovascular events in vitamin K antagonists–naive patients with atrial fibrillation

Daniele Pastori, Pasquale Pignatelli, Francesco Cribari, Roberto Carnevale, Mirella Saliola, Francesco Violi, Professor Gregory Lip

Article2017

Renal Function, Time in Therapeutic Range and Outcomes in Warfarin-Treated Atrial Fibrillation Patients: A Retrospective Analysis of Nationwide Registries

Anders Nissen Bonde, Professor Gregory Lip, Anne‐Lise Kamper, Laila Stærk, Christian Torp‐Pedersen, Gunnar Gislason, Jonas Bjerring Olesen

Article2017

Importance of time in therapeutic range on bleeding risk prediction using clinical risk scores in patients with atrial fibrillation

José Miguel Rivera‐Caravaca, Vanessa Roldán, María Asunción Esteve‐Pastor, Mariano Valdés, Vicente Vicente, Professor Gregory Lip, Francisco Marı́n